Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ekso Bionics Holdings (EKSO) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Ekso Bionics Holdings (EKSO) over the last 14 years, with Q3 2025 value amounting to $12.0 million.

  • Ekso Bionics Holdings' Total Liabilities fell 1643.77% to $12.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.0 million, marking a year-over-year decrease of 1643.77%. This contributed to the annual value of $13.9 million for FY2024, which is 1451.08% down from last year.
  • Ekso Bionics Holdings' Total Liabilities amounted to $12.0 million in Q3 2025, which was down 1643.77% from $12.2 million recorded in Q2 2025.
  • In the past 5 years, Ekso Bionics Holdings' Total Liabilities registered a high of $16.3 million during Q4 2023, and its lowest value of $8.8 million during Q2 2022.
  • Moreover, its 5-year median value for Total Liabilities was $14.3 million (2024), whereas its average is $13.6 million.
  • In the last 5 years, Ekso Bionics Holdings' Total Liabilities crashed by 4245.43% in 2021 and then skyrocketed by 8404.05% in 2023.
  • Ekso Bionics Holdings' Total Liabilities (Quarter) stood at $11.9 million in 2021, then increased by 29.41% to $15.5 million in 2022, then rose by 5.5% to $16.3 million in 2023, then decreased by 14.51% to $13.9 million in 2024, then decreased by 14.08% to $12.0 million in 2025.
  • Its Total Liabilities stands at $12.0 million for Q3 2025, versus $12.2 million for Q2 2025 and $14.6 million for Q1 2025.